Creatine and Muscle Health in Madrid's Walking Footballers.
MyoCreaWalk
Effects of Creatine Supplementation on Muscle Health in Madrid's Older Walking Footballers
2 other identifiers
interventional
20
0 countries
N/A
Brief Summary
Healthy aging requires effective, accessible, and sustainable interventions capable of preserving functional capacity and preventing age-related decline. In this context, walking football has emerged as a safe, inclusive physical exercise modality with high adherence among older adults, demonstrating benefits for muscle health, metabolic profile, and psychosocial well-being. On the other hand, creatine monohydrate supplementation is backed by robust scientific evidence as a strategy to enhance exercise adaptations, promote muscle mass maintenance, and improve factors related to metabolic syndrome. The objective of this project is to evaluate the effects of creatine supplementation combined with regular walking football practice on muscle quality and metabolic profile in older adults, as well as to explore the underlying biological mechanisms using a cell culture-based experimental model. The ultimate goal is to determine the potential of this intervention to promote healthy longevity through functional, muscular, and metabolic indicators associated with healthspan. Specifically, the study will analyze the intervention's effects on body composition, physical fitness, and metabolic syndrome markers; evaluate its impact on psychosocial well-being, quality of life, and cognitive function; and investigate the molecular mechanisms related to muscle health, protection against oxidative stress, and the modulation of senescence using an ex vivo/in vitro model. The project will be carried out in two complementary phases. First, a longitudinal experimental study will be conducted in older adults participating in walking football programs and supplemented with creatine. Subsequently, skeletal muscle cultures will be exposed to conditioned sera obtained before and after the intervention to investigate its biological effects. This approach will integrate the evaluation of clinical efficacy with the study of the underlying mechanisms, generating applicable knowledge for designing personalized, sustainable, and cost-effective strategies to prevent sarcopenia and metabolic syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 1, 2026
CompletedStudy Start
First participant enrolled
October 20, 2026
CompletedFirst Posted
Study publicly available on registry
October 23, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 20, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
October 23, 2026
October 1, 2026
8 months
October 1, 2026
October 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Muscle Quality
It is defined as the capacity of skeletal muscle to generate strength relative to its mass, integrating both structural and functional aspects. It will be expressed as the ratio between the estimated 1-RM strength and muscle mass measured by dual-energy X-ray absorptiometry (DEXA)
From enrollment to the end of treatment at 32 weeks
Secondary Outcomes (63)
Nutritional profile
From enrollment to the end of treatment at 32 weeks
Body composition
From enrollment to the end of treatment at 32 weeks
Body composition
From enrollment to the end of treatment at 32 weeks
Body composition
From enrollment to the end of treatment at 32 weeks
Body composition
From enrollment to the end of treatment at 32 weeks
- +58 more secondary outcomes
Other Outcomes (3)
Characterization variables (collected through interview and individual history)
At enrollment time
Characterization variables (collected through interview and individual history)
At enrollment time
Characterization variables (collected through interview and individual history)
At enrollment time
Study Arms (1)
Creatine + Walking Football training Group
EXPERIMENTALSingle-arm, prospective interventional trial with a within-subject (pre-post) design, where each participant serves as his or her own control.
Interventions
Participants will be assessed at baseline, after 16 weeks of supervised Walking Football training, and again after a further 16 weeks of Walking Football combined with daily creatine monohydrate supplementation. This within-subject design allows each participant to serve as their own control when evaluating the effects of creatine supplementation beyond those attributable to Walking Football training alone.
Eligibility Criteria
You may qualify if:
- Individuals over 50 years of age
- Minimum physical activity level recommended by the World Health Organization (≥150 minutes of moderate-intensity activity or ≥75 minutes of vigorous-intensity activity per week)
- Men and women with regular participation (≥2 times per week) in walking football training for at least 6 months
- Voluntary acceptance to participate in the study after having read, understood, and signed the informed consent form.
You may not qualify if:
- Presence of metabolic, neuromuscular, cardiovascular, or joint diseases that contraindicate moderate-to-vigorous physical activity and/or creatine supplementation
- Current use of creatine nutritional supplements or other ergogenic compounds
- Having any comprehension difficulties or presenting musculoskeletal alterations that influence the assessments
- Being under pharmacological treatment that may alter muscle mass or function
- Cognitive impairment or alteration that prevents following the protocol indications.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universidad Europea de Madridlead
- Universidad Politecnica de Madridcollaborator
- Crown Sport Nutritioncollaborator
Related Publications (9)
Candow DG, Zello GA, Ling B, Farthing JP, Chilibeck PD, McLeod K, Harris J, Johnson S. Comparison of creatine supplementation before versus after supervised resistance training in healthy older adults. Res Sports Med. 2014;22(1):61-74. doi: 10.1080/15438627.2013.852088.
PMID: 24392772BACKGROUNDAmiri E, Sheikholeslami-Vatani D. The role of resistance training and creatine supplementation on oxidative stress, antioxidant defense, muscle strength, and quality of life in older adults. Front Public Health. 2023 May 2;11:1062832. doi: 10.3389/fpubh.2023.1062832. eCollection 2023.
PMID: 37206869BACKGROUNDDobrowolski P, Prejbisz A, Kurylowicz A, Baska A, Burchardt P, Chlebus K, Dzida G, Jankowski P, Jaroszewicz J, Jaworski P, Kaminski K, Kaplon-Cieslicka A, Klocek M, Kukla M, Mamcarz A, Mastalerz-Migas A, Narkiewicz K, Ostrowska L, Sliz D, Tarnowski W, Wolf J, Wylezol M, Zdrojewski T, Banach M, Januszewicz A, Bogdanski P. Metabolic syndrome - a new definition and management guidelines: A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, "Club 30" Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons. Arch Med Sci. 2022 Aug 30;18(5):1133-1156. doi: 10.5114/aoms/152921. eCollection 2022. No abstract available.
PMID: 36160355BACKGROUNDChilibeck PD, Kaviani M, Candow DG, Zello GA. Effect of creatine supplementation during resistance training on lean tissue mass and muscular strength in older adults: a meta-analysis. Open Access J Sports Med. 2017 Nov 2;8:213-226. doi: 10.2147/OAJSM.S123529. eCollection 2017.
PMID: 29138605BACKGROUNDMasfiah S, Kurnialandi A, Meij JJ, Maier AB. Definitions of healthspan: A systematic review. Ageing Res Rev. 2025 Sep;111:102806. doi: 10.1016/j.arr.2025.102806. Epub 2025 Jun 14.
PMID: 40523529BACKGROUNDCruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019 Jan 1;48(1):16-31. doi: 10.1093/ageing/afy169.
PMID: 30312372BACKGROUNDOudot A, Martin C, Busseuil D, Vergely C, Demaison L, Rochette L. NADPH oxidases are in part responsible for increased cardiovascular superoxide production during aging. Free Radic Biol Med. 2006 Jun 15;40(12):2214-22. doi: 10.1016/j.freeradbiomed.2006.02.020. Epub 2006 Mar 23.
PMID: 16785035BACKGROUNDGoddard G, Rajagopal S, Wahbah Makhoul G, Raji MA. Metabolic Syndrome in Older Adults: Through the Lens of Institute for Healthcare Improvement's (IHI) 4Ms Framework and Social Determinants of Health. Life (Basel). 2025 Aug 28;15(9):1370. doi: 10.3390/life15091370.
PMID: 41010311BACKGROUNDShort KR, Vittone JL, Bigelow ML, Proctor DN, Nair KS. Age and aerobic exercise training effects on whole body and muscle protein metabolism. Am J Physiol Endocrinol Metab. 2004 Jan;286(1):E92-101. doi: 10.1152/ajpendo.00366.2003. Epub 2003 Sep 23.
PMID: 14506079BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tamara Iturriaga Ramirez, PhD
Facultad de Medicina, Salud y Deportes, Departamento de Ciencias del Deporte, Universidad Europea de Madrid
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
October 1, 2026
First Posted
October 23, 2026
Study Start
October 20, 2026
Primary Completion (Estimated)
June 20, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
October 23, 2026
Record last verified: 2026-10
Data Sharing
- IPD Sharing
- Will not share